State Street Corp Adicet Bio, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Adicet Bio, Inc. stock. As of the latest transaction made, State Street Corp holds 229,721 shares of ACET stock, worth $211,343. This represents 0.0% of its overall portfolio holdings.

Number of Shares

229,721

Previous 244,821 6.17%

Holding current value

$211,343

Previous $296,000 11.49%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.07 - $1.63 $16,157 - $24,613	-15,100 Reduced 6.17%	229,721 $330,000
Q2 2024 Aug 14, 2024	SELL	$1.21 - $2.4 $841,449 - $1.67 Million	-695,413 Reduced 73.96%	244,821 $296,000
Q1 2024 May 15, 2024	BUY	$1.76 - $3.45 $527,456 - $1.03 Million	299,691 Added 46.79%	940,234 $2.21 Million
Q4 2023 Feb 14, 2024	BUY	$1.11 - $1.89 $7,781 - $13,248	7,010 Added 1.11%	640,543 $1.21 Million
Q3 2023 Nov 14, 2023	BUY	$1.37 - $3.4 $95,583 - $237,214	69,769 Added 12.38%	633,533 $867,000
Q2 2023 Aug 14, 2023	SELL	$2.13 - $7.13 $1,476 - $4,941	-693 Reduced 0.12%	563,764 $1.37 Million
Q1 2023 May 15, 2023	SELL	$5.52 - $9.23 $9.5 Million - $15.9 Million	-1,720,129 Reduced 75.29%	564,457 $3.25 Million
Q4 2022 Feb 14, 2023	BUY	$7.72 - $21.27 $2.52 Million - $6.94 Million	326,321 Added 16.66%	2,284,586 $20.4 Million
Q3 2022 Nov 15, 2022	BUY	$13.43 - $18.74 $19.9 Million - $27.8 Million	1,482,409 Added 311.52%	1,958,265 $27.8 Million
Q2 2022 Aug 15, 2022	BUY	$10.26 - $20.81 $811,442 - $1.65 Million	79,088 Added 19.93%	475,856 $6.95 Million
Q1 2022 May 16, 2022	BUY	$11.53 - $19.97 $799,340 - $1.38 Million	69,327 Added 21.17%	396,768 $7.92 Million
Q4 2021 Feb 14, 2022	BUY	$7.37 - $17.49 $229,899 - $545,583	31,194 Added 10.53%	327,441 $5.73 Million
Q3 2021 Nov 15, 2021	BUY	$6.29 - $9.93 $283,364 - $447,346	45,050 Added 17.93%	296,247 $2.32 Million
Q2 2021 Aug 16, 2021	BUY	$9.19 - $15.93 $2.21 Million - $3.83 Million	240,687 Added 2290.08%	251,197 $2.59 Million
Q1 2021 May 17, 2021	SELL	$12.12 - $17.17 $60,066 - $85,094	-4,956 Reduced 32.04%	10,510 $137,000
Q3 2020 Nov 10, 2020	BUY	$10.18 - $21.4 $157,443 - $330,972	15,466 New	15,466 $184,000

Others Institutions Holding ACET

# of Institutions

Shares Held

59.2M

Call Options Held

4.2K

Put Options Held

6.7K

View Full List

About Adicet Bio, Inc.

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $36.8M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

More about ACET

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Adicet Bio, Inc. Transaction History